Influenza testing and antiviral prescribing practices among emergency department clinicians in 9 states during the 2006 to 2007 influenza season.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 20116012)

Published in Ann Emerg Med on January 01, 2010

Authors

Mark R Mueller1, Philip J Smith, Joan P Baumbach, John P Palumbo, James I Meek, Ken Gershman, Meredith Vandermeer, Ann R Thomas, Christine E Long, Ruth Belflower, Nancy L Spina, Karen G Martin, Ruth Lynfield, Kyle P Openo, Pamala D Kirley, Lauren E Pasutti, Brenda G Barnes, William Schaffner, Laurie Kamimoto

Author Affiliations

1: New Mexico Department of Health, Santa Fe, NM.

Articles by these authors

Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA (2007) 26.98

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med (2009) 16.13

Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med (2003) 15.48

Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med (2005) 12.75

Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA (2003) 12.04

Multistate point-prevalence survey of health care-associated infections. N Engl J Med (2014) 8.78

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis (2010) 8.37

Burden of Clostridium difficile infection in the United States. N Engl J Med (2015) 8.17

Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med (2006) 7.68

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis (2007) 6.45

Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA (2008) 6.13

Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA (2010) 5.94

Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis (2011) 5.58

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet (2006) 5.56

Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet (2011) 5.43

The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis (2007) 5.36

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA (2005) 5.29

Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis (2008) 4.91

A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med (2002) 4.88

Health care-associated invasive MRSA infections, 2005-2008. JAMA (2010) 4.79

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med (2009) 4.38

National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med (2013) 4.21

Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med (2005) 4.04

Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin Infect Dis (2010) 3.61

Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med (2003) 3.54

Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA (2004) 3.05

Bacterial meningitis in the United States, 1998-2007. N Engl J Med (2011) 2.99

Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA (2006) 2.93

Prevention of hepatitis A with the hepatitis A vaccine. N Engl J Med (2004) 2.87

Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis (2007) 2.60

Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One (2010) 2.59

Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis (2009) 2.56

Accuracy and interpretation of rapid influenza tests in children. Pediatrics (2007) 2.43

Epidemiology of 2009 pandemic influenza A (H1N1) in the United States. Clin Infect Dis (2011) 2.40

Outbreak of variant influenza A(H3N2) virus in the United States. Clin Infect Dis (2013) 2.38

Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep (2010) 2.31

Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics (2008) 2.29

Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med (2009) 2.25

Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg Infect Dis (2006) 2.25

Spatial analysis of human granulocytic ehrlichiosis near Lyme, Connecticut. Emerg Infect Dis (2002) 2.21

An outbreak of community-acquired foodborne illness caused by methicillin-resistant Staphylococcus aureus. Emerg Infect Dis (2002) 2.15

Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus. Antimicrob Agents Chemother (2005) 2.14

Pseudomonas aeruginosa and Serratia marcescens contamination associated with a manufacturing defect in bronchoscopes. N Engl J Med (2003) 2.09

Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J Clin Microbiol (2009) 2.06

The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J (2011) 2.05

Surveillance for influenza during the 2009 influenza A (H1N1) pandemic-United States, April 2009-March 2010. Clin Infect Dis (2011) 1.98

Hospitalized patients with 2009 pandemic influenza A (H1N1) virus infection in the United States--September-October 2009. Clin Infect Dis (2011) 1.95

Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study. J Infect Dis (2011) 1.91

Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis (2004) 1.84

Outbreak of osteomyelitis/septic arthritis caused by Kingella kingae among child care center attendees. Pediatrics (2005) 1.83

Acute selenium toxicity associated with a dietary supplement. Arch Intern Med (2010) 1.78

Geographic poverty and racial/ethnic disparities in cervical cancer precursor rates in Connecticut, 2008-2009. Am J Public Health (2012) 1.76

The first rotavirus vaccine and intussusception: epidemiological studies and policy decisions. J Infect Dis (2003) 1.73

Racial/ethnic disparities in preschool immunizations: United States, 1996-2001. Am J Public Health (2004) 1.72

The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: evidence of continuing racial and ethnic differences. J Acquir Immune Defic Syndr (2006) 1.71

Parent attitudes toward immunizations and healthcare providers the role of information. Am J Prev Med (2005) 1.71

Distribution of SR protein exonic splicing enhancer motifs in human protein-coding genes. Nucleic Acids Res (2005) 1.70

Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am J Med (2005) 1.68

Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era. J Infect Dis (2010) 1.68

Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med (2006) 1.67

Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004. Vaccine (2006) 1.65

American College of Chest Physicians and American Association for Bronchology [corrected] consensus statement: prevention of flexible bronchoscopy-associated infection. Chest (2005) 1.64

Individual and geographic disparities in human papillomavirus types 16/18 in high-grade cervical lesions: Associations with race, ethnicity, and poverty. Cancer (2013) 1.64

Sickle cell trait, hemoglobin C trait, and invasive pneumococcal disease. Epidemiology (2010) 1.63

Adjustments for non-telephone bias in random-digit-dialling surveys. Stat Med (2003) 1.62